A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors

Clinical trial NCT01358227 · COMPLETED

Trial details

NCT number: NCT01358227
Sponsor: Proacta, Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2006-12-01
Primary completion: 2009-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.